ALEAF What the company is about to do is more significant than "Parting the Red Sea", and here's hoping they know how humongous the financial information is and the company will be remembered for their actions on November 26th 2018.
Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) ("Aleafia") or (the "Company"), a highly differentiated cannabis company with major cannabis cultivation and medical clinic operations, will release its financial results and hold its Third Quarter Results Call on November 26, 2018.
The Results Call, the first in the company's history, will be held at 8:30am (EST) on November 26, 2018 and will allow for shareholders and the broader investment community to direct questions to Aleafia senior management.
Aleafia Third Quarter Highlights:
-- Secured first medical cannabis sale in company's history, only days after securing Sales Licence from Health Canada
-- Fully funded annual growing capacity of 98,000 kg of cannabis flower in 2019, with Port Perry secure outdoor grow expansion
-- Signed supply MOU with CannTrust Holdings Inc. for up 15,000 kg of cannabis in 2019
-- Added to Horizons Marijuana Life Sciences ETF, the largest cannabis ETF in the world
-- Submitted application to list on NASDAQ
Canadian and international call-in numbers for the Results Call will be provided by November 23, 2018.
Aleafia is a vertically integrated, national cannabis company with major medical clinic, cannabis cultivation and R&D operations. The company is a federally licensed producer and vendor of cannabis and will reach an annual production capacity of 98,000 kg of dried cannabis in 2019.
Aleafia operates 22 medical cannabis clinics staffed by physicians and nurse practitioners, with over 50,000 patients. The company is highly differentiated, maintaining the largest medical cannabis dataset in the world with significant intellectual property holdings and current R&D operations.
Break the ceiling and "GAME ON"
